Furthermore, while it is somewhat surprising that increases in TVB-N appeared rapid between months 4 and 6 of treated GRS groups given its low yet limited values hence not clearly distinct to stand as per ‘noticeable significant effects’, suggests
the use of TBA not the very best for this specific scenario to explain the lipid damage of freeze-processed samples under MAP combined treatments.